Healthpeak Properties, Inc. reports developments for a fully integrated REIT that owns, operates, and develops real estate for healthcare discovery and delivery. News releases center on operating results, non-GAAP financial measures, earnings guidance, monthly common stock dividends, and portfolio activity across healthcare real estate assets.
Company updates also cover capital allocation and balance-sheet actions, including unsecured term loan financing, senior notes, joint venture transactions, and Healthpeak’s relationship with Janus Living, a senior housing REIT that completed its IPO. Governance and shareholder voting announcements appear alongside earnings-call and conference-presentation updates.
Healthpeak Properties (NYSE: DOC) closed a new $400 million unsecured delayed-draw term loan facility that matures in March 2031. Borrowings carry interest at SOFR + 80 bps based on current credit ratings and the facility was undrawn at closing.
The credit was arranged by BofA Securities, JPMorgan, and Wells Fargo Securities, with Bank of America serving as administrative agent. Management said the Term Loan enhances liquidity, financial flexibility, and strengthens the balance sheet.
Healthpeak Properties (NYSE: DOC) and Janus Living (NYSE: JAN) announced that Janus Living completed an initial public offering of 48,300,000 Class A-1 shares at $20.00 per share, including full exercise of a 6,300,000-share underwriter option. Shares began trading on March 20, 2026 under JAN.
Net proceeds were approximately $878 million, to be used for acquisitions, investments meeting Janus Living’s criteria and general corporate purposes. Lead book-runners were BofA Securities and J.P. Morgan.
Healthpeak Properties (NYSE:DOC) and Janus Living priced Janus Living’s upsized IPO of 42,000,000 Class A-1 shares at $20.00 per share, with a 30-day underwriter option for an additional 6,300,000 shares. Janus Living expects NYSE trading to begin on March 20, 2026 under ticker JAN, and closing is expected on March 23, 2026, subject to customary conditions.
After the IPO, Healthpeak will own approximately 214,734,000 Janus Living shares, representing an approximate 83.6% voting interest (81.6% if the option is fully exercised). Proceeds will be used for acquisitions, investments, and general corporate purposes.
Healthpeak Properties (NYSE: DOC) and Janus Living launched an initial public offering of 37,000,000 Class A-1 shares, with an expected price range of $18.00–$20.00 per share and a 30-day overallotment option for 5,550,000 additional shares. Janus Living expects NYSE listing under "JAN".
Janus Living intends to use net proceeds for acquisition and investment opportunities and general corporate purposes. Healthpeak would retain approximately 85.3% economic interest (83.4% if option exercised). The registration statement on Form S-11 has been filed but is not yet effective.
Healthpeak Properties (NYSE:DOC) announced that Janus Living, Inc. filed a registration statement on Form S-11 with the SEC for a proposed initial public offering of its Class A-1 common stock.
Janus Living intends to list under ticker JAN; offering terms, share count and pricing are not yet determined. The offering is subject to market conditions, regulatory approvals, completion of related financings, and SEC review. BofA Securities and J.P. Morgan are lead book-running managers. A preliminary prospectus will be available once filed; securities cannot be sold until the registration is declared effective.
Healthpeak Properties (NYSE: DOC) reported Q4 2025 results and strategic initiatives, including an announced IPO of Janus Living to separate senior housing, a $600 million Gateway Crossing campus acquisition, and a 2026 opportunistic capital recycling plan targeting $1 billion of dispositions and recapitalizations.
Q4 results: Nareit FFO $0.47 per share, AFFO $0.40 per share, Total Same-Store Cash (Adjusted) NOI +3.9%, and Net Debt to Adjusted EBITDAre 5.2x. Board declared monthly dividends totaling $0.305 for Q1 2026 (annualized $1.22).
Healthpeak (NYSE: DOC) announced on January 21, 2026 that Omkar Joshi has joined as Head of Enterprise Innovation. In this newly created role, Joshi will lead technology, automation, and data initiatives and oversee rollout of the company’s agentic operating system to improve back-office performance and tenant experience. Joshi joins from Palantir Technologies, where he spent nearly a decade deploying operational AI across healthcare, pharmaceuticals, banking, manufacturing and real estate solutions. Leadership says the hire aims to accelerate automation, real-time data unification, and technology-enabled operations across property operations, facilities engineering, and accounting.
Summary not available.
Healthpeak Properties (NYSE: DOC) announced approximately $925 million of transaction activity that advances its capital allocation strategy. Key moves include a $600 million purchase of a 1.4-million sq ft Gateway Boulevard campus in South San Francisco (29 acres, ~60% occupied) and $325 million of outpatient medical dispositions (~834,000 sq ft) closed in Q4 2025. Healthpeak now controls roughly 6.5 million sq ft across 210 acres in South San Francisco. The company said additional outpatient medical sales, recapitalizations, and loan repayments could generate ~$700 million or more of proceeds to recycle into life science assets, pre-leased developments, or share repurchases.
Healthpeak Properties (NYSE: DOC) will report fourth quarter 2025 results after the NYSE close on Monday, February 2, 2026. The company will host a conference call and webcast to review results on Tuesday, February 3, 2026 at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time). Participants can join via the company website webcast, the provided webcast link, or by telephone.
An archive of the webcast will be available on Healthpeak’s website through February 2, 2027, and a telephonic replay is available through February 10, 2026 using conference ID 95156.